Minireviews
Copyright ©The Author(s) 2019.
World J Gastroenterol. Sep 7, 2019; 25(33): 4870-4884
Published online Sep 7, 2019. doi: 10.3748/wjg.v25.i33.4870
Table 1 Prevalence of oipA “on” status among isolates from various geographical regions
CountryNumber of patientsStudy populationoipA “on” prevalenceAssociation with other virulence genes
North-Eastern Brazil[30]95Adults with gastritis, GC and their first degree relatives, asymptomatic children81.1%cagAvacA s1 m1
Iran[31]53Adults and children with chronic gastritis, PUD, intestinal metaplasia and GC79.0%cagA, vacA s1 m1
Venezuela[32]113Adults with chronic gastritis83.0%NA
Bulgaria[33]70Symptomatic adults81.0%cagA, vacA s1, m1 and m2
Malaysia and Singapore[34]159Adults with functional dyspepsia, GC and PUD89.4%vacA m1/m2
Italy[35]90Adults with chronic gastritis and PUD77.4%babA2, hopQ
Colombia and United States[36]200Patients with gastritis, PUD and GC79.3%cagA, babA
Germany[26]58Patients with chronic gastritis59.0%cagA, vacA s1, babA
Netherlands[37]96Adults with chronic gastritis, PUD, GC and lymphoma72.0%cag PAI+
Italy[27]60Adults with chronic gastritis, PUD and duodenitis60.0%cagA, vacA s1 and m1, babA
East Asia and India[38]54Adults with gastritis and PUD100.0%cagA, vacA s1
Western countries[38]55Adults with gastritis and PUD63.6%cagA, vacA s1
Table 2 Overview of studies on homB prevalence and clinical significance in adults and children
CountryStudy populationNumber of patientshomB prevalenceClinical relevance of homBAssociation with other virulence genes
Western countries[43]Adults23453.8Significant, PUDvacA s1, cagA+
East Asian countries[43]Adults13886.8NSNS
Western countries[46]Adults30056.0NANA
East Asian countries[46]Adults13886.6NANA
Burkina Faso[46]Adults1190.9NANA
Colombia, United States[47]Adults28661.2Significant, GCcagA+
Iran[45]Adults13843.5Significant, GCcagA+
Iraq[48]NA7029.9NSNS
Turkey[48]NA6433.9NSNS
South Korea[44]Children and adults26069.2NSvacA
Portugal[49]Children4558.4Significant, PUDNA
Adults9057.7NSNA
Portugal[42]Children8457.3Significant, PUDcagA+, vacA s1, babA2+, hopQI, oipA “on”
Adults10656.8Significant only in ≤ 40 yr of age, PUD
Portugal[22]Children11753.5Significant, PUDjhp0562
Slovenia[50]Children28540.7NSNS